Loading…

Cellebrite DI Ltd.CLBTCompetitor analysis, valuation and peers

United States · USD·Information Technology›Packaged Software

Makes digital forensics technology that extracts and analyzes data from mobile devices for law enforcement and investigations.

Momentum weak 27
Mkt cap
$2.80B
US dollars, full cap
Free float
50%
of shares outstanding
$/day
$27.5M
20-day average traded
Fwd P/E
30.1×
forward earnings
ROIC−WACC
+34.6 pp
WACC 10.3%
Hurdle
-2 pp
Req g minus delivered
Next earnings
91 days
17 Feb 2027
Close · USD$11.16
1D+4.8%
1W-12.1%
1M-1.9%
3M-30.4%
6M-14.5%
YTD-38.1%
1Y-26.9%
ATR %5.7%
Beta0.75
52w lowhigh44.1% off high

What Cellebrite DI does

Makes digital forensics technology that extracts and analyzes data from mobile devices for law enforcement and investigations.

Sells subscriptions and licences to law enforcement, increasingly annual contracts for forensic software, with a smaller part from perpetual licences and hardware. Sales go through direct teams and resellers. It listed in the US in 2021 through a merger with a blank-check company.

Products and services

  • Mobile device data extraction
  • Digital forensic analytics
  • Enterprise investigative solutions

Customers

  • Law enforcement/government agencies
  • Enterprises (internal investigations)

Where it sits in the supply chain

  • Information technology
  • Digital forensics/security
  • Mobile device forensics & investigative…

What could go right

  • Growing government/law enforcement digital forensics budgets
  • Enterprise investigative use case expansion

What could go wrong

  • Device maker security updates reducing extraction capability
  • Government export/regulatory restrictions

Moat: narrow (regulatory licence, IP / patents, installed base). Deep law-enforcement relationships and specialized forensic technology create high barriers to entry.

Headquarters: Petah Tikva, Israel · Founded: 1999 · Employees: 1,285

Named competitors

  • Magnet Forensics private or unlisted
  • Oxygen Forensics private or unlisted
  • MSAB private or unlisted
  • OpenText OTEX.TO
  • Cognyte Software CGNT

Cellebrite DI at a glance

Size Cellebrite DI (CLBT) is a United States Information Technology company (Packaged Software) with a market value of $2.80B, the 1586th largest of 3,085 United States companies the cockpit tracks. Shares closed at $11.16 on 18 Nov 2026.

Performance Over six months the shares fell 14.5%, against -15.5% for the median peer and -2.2% for the United States market (cap-weighted) — 11th highest of 21 in its peer set.

Growth Revenue grew 17.9% over the last twelve months (peer median +9.9%); the operating margin is 12.6% (peer median 6.4%).

Valuation It trades at 30.1× forward earnings against a peer median of 20.3× (4th most expensive of 17).

Price implies For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +20%, so the hurdle is -2 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 34.6 points above its cost of capital (10.3% WACC).

Backlog Backlog (remaining performance obligations) was $345M at 30 Jun 2025. Backlog detail →

Short interest Short interest is 2.2% of the free float (30 Oct 2026).

Next results Next results expected around 17 Feb 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 2026CLBT 88Peer median 87
Six months, rebased to 100: Cellebrite DI against the median of its 20 peers (local-currency closes).

Cellebrite DI financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$537M$476M$401M$325M$271M
Revenue growth—+19%+23%+20%—
Gross profit$442M$401M$339M$272M$220M
EBITDA$96.8M$82.7M$67.7M$43.3M$12.2M
Net income$64.7M$77.8M-$283M-$81.1M$116M
Free cash flow$166M$160M$124M$96.8M$13.7M
Capital expenditure$38.9M$13.2M$10.6M$7.92M$9.09M
Total debt$23.4M$22.7M$11.0M$14.1M$15.4M

Quarterly statements and history in the cockpit →

Cellebrite DI competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%+40%-20%0%+20%SPSCVERX002624URBANCOTATATECH300085002065SINCH002153WIX001339BLSH000158PLUSMNDY688615HEXTALRMCLBT6-month return →1-month return →
Up and to the right = strong over both horizons. Cellebrite DI is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%0×200×400×SPSCVERX002624TATATECH002065SINCH002153WIX001339BLSHMNDYCLBTRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Cellebrite DI is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%SPSCVERX002624TATATECH002065SINCHWIX600100BLSHPLUSMNDY688615HEXT2400ALRMCLBTGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Cellebrite DI is the large dot.

Cellebrite DI competitors and peer comparison

Head to head with its named competitors (CLBT vs OTEX.TO vs CGNT)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Cellebrite DI CLBT$2.80B-14%+18%13%30.1×17.1%
Open Text OTEX.TO$5.55B+5%-1%23%6.0×-6.8%
Cognyte Software CGNT$586M-20%+28%5%12.5×22.0%

How Cellebrite DI compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Cellebrite DI against its 20 peers (data as of 18 Nov 2026)
MeasureCLBTPeer medianRank in peer set
1-month return-1.9%-4.6%7th highest of 21
6-month return-14.5%-15.5%11th highest of 21
Distance from 52-week high-44.1%-46.2%10th highest of 21
Revenue growth (TTM)+17.9%+9.9%7th highest of 21
Operating margin12.6%6.4%8th highest of 21
Forward P/E30.1×20.3×4th most expensive of 17
Growth the price implies (Req g, 7 yrs)17.1%14.4%6th most demanding of 16
Growth delivered (Del g)+19.5%+14.8%4th highest of 16
Hurdle (Req g minus delivered)-2.4 pp-1.6 pp8th least demanding of 16
ROIC minus cost of capital+34.6 pp-2.9 pp2nd highest of 18
EV / EBITDA24.2×15.4×3rd most expensive of 11
Net debt / EBITDA-4.8×-0.2×2nd least indebted of 11

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Cellebrite DI CLBTUnited States$2.80B-14%+18%13%30.1×17.1%+19.5%
SPS Commerce SPSCUnited States$2.81B+47%+7%17%14.8×7.1%+19.2%
Vertex VERXUnited States$2.81B+28%+10%2%17.5×46.2%+14.8%
Perfect World 002624.SZChina$2.78B-39%-8%8%20.4×15.5%-8.2%
Urban URBANCO.NSIndia$2.85B+42%+36%-26%n/an/an/a
Tata Technologies TATATECH.NSIndia$2.85B-2%+22%13%34.5×28.2%+18.3%
Shenzhen Infogem Technologies 300085.SZChina$2.75B-33%+2%-11%n/an/an/a
DHC Software 002065.SZChina$2.87B-25%-4%3%37.3×13.8%+7.1%
Sinch SINCH.STSweden$2.88B+7%-3%4%13.0×20.6%+27.5%
Beijing Shiji Information Technology 002153.SZChina$2.71B-28%-4%-3%441.3×n/an/a
Wix.com WIXUnited States$2.66B+16%+14%-4%11.0×-4.1%+15.2%
JWIPC Technology 001339.SZChina$2.65B-28%+41%21%20.2×n/an/a
Tsinghua Tongfang 600100.SSChina$3.00B-28%-11%-2%n/a29.5%-10.3%
Bullish BLSHUnited States$3.06B-45%+34%16%25.3×31.7%+14.4%
Shijiazhuang Changshan Beiming Technology 000158.SZChina$3.08B-26%-14%2%n/an/an/a
ePlus PLUSUnited States$2.52B+17%+12%7%16.2×6.2%+9.5%
monday.com MNDYUnited States$3.13B-6%+22%6%10.2×14.4%+50.2%
Intsig Information 688615.SSChina$2.49B-39%+24%22%29.6×9.2%+22.1%
Hexaware Technologies HEXT.NSIndia$3.18B-5%+13%12%21.0×14.9%+16.5%
XD, Inc. 2400.HKHong Kong$2.47B-25%+6%26%10.6×0.7%+14.3%
Alarm.com ALRMUnited States$3.26B+51%+9%13%22.2×10.5%+10.3%

Cellebrite DI backlog

Cellebrite DI reported $345M of remaining performance obligations at 30 Jun 2025.

Questions

Who are Cellebrite DI's main competitors?
Named competitors: Magnet Forensics (private or unlisted), Oxygen Forensics (private or unlisted), MSAB (private or unlisted), OpenText (OTEX.TO), Cognyte Software (CGNT). The cockpit's measured peer set (industry) also includes SPS Commerce (SPSC), Vertex (VERX), Perfect World (002624.SZ), Urban (URBANCO.NS), Tata Technologies (TATATECH.NS), Shenzhen Infogem Technologies (300085.SZ).
Is Cellebrite DI expensive compared with its peers?
On forward p/e it trades at 30.1× against a peer median of 20.3×, 4th most expensive of 17 in its peer set. For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +20%, so the hurdle is -2 pp: the price already allows for a slowdown.
How has Cellebrite DI stock performed?
Over six months to 18 Nov 2026 the shares returned -14.5% against -15.5% for the median peer; over one year -26.9%.
What is Cellebrite DI's backlog?
Cellebrite DI's remaining performance obligations (contracted revenue not yet recognised) were $345M at 30 Jun 2025.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.